The genetic basis of cerebral palsy

Developmental Medicine and Child Neurology

Volumn 59, Issue 5, 2017, Pages 462-469

  Fahey, Michael C ^a   Maclennan, Alastair H ^b   Kretzschmar, Doris ^c   Gecz, Jozef ^b,d   Kruer, Michael C ^e,f,g  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d SOUTH AUSTRALIAN HEALTH AND MEDICAL RESEARCH INSTITUTE   (Australia)

^e UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^f ARIZONA STATE UNIVERSITY   (United States)

^g PHOENIX CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; OSTEOPONTIN;

ADAPTOR PROTEIN 4 GENE; ADD3 GENE; ALLELE; AUTISM; CEREBRAL PALSY; GENE; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC VARIATION; GENETICS; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; INTELLECTUAL IMPAIRMENT; KANK1 GENE; NERVE CELL DIFFERENTIATION; NEUROBIOLOGY; PATHOGENESIS; POINT MUTATION; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOPHILIA; VALIDATION STUDY; COPY NUMBER VARIATION; MUTATION; RISK FACTOR;

CEREBRAL PALSY; DNA COPY NUMBER VARIATIONS; HUMANS; MUTATION; RISK FACTORS;

EID: 85009188317     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/dmcn.13363     Document Type: Review

References (66)

1. Badawi N, Keogh JM. Causal pathways in cerebral palsy. J Paediatr Child Health 2013; 49: 5–8.
2. Ellenberg JH, Nelson KB. The association of cerebral palsy with birth asphyxia: a definitional quagmire. Dev Med Child Neurol 2013; 55: 210–16.
3. Paneth N, Hong T, Korzeniewski S. The descriptive epidemiology of cerebral palsy. Clin Perinatol 2006; 33: 251–67.
4. Strijbis EM, Oudman I, van Essen P, MacLennan AH. Cerebral palsy and the application of the international criteria for acute intrapartum hypoxia. Obstet Gynecol 2006; 107: 1357–65.
5. Hankins GD, Speer M. Defining the pathogenesis and pathophysiology of neonatal encephalopathy and cerebral palsy. Obstet Gynecol 2003; 102: 628–36.
6. MacLennan A. A template for defining a causal relation between acute intrapartum events and cerebral palsy: international consensus statement. BMJ 1999; 319: 1054–59.
7. Sigurdardottir S, Thorkelsson T, Halldorsdottir M, Thorarensen O, Vik T. Trends in prevalence and characteristics of cerebral palsy among Icelandic children born 1990 to 2003. Dev Med Child Neurol 2009; 51: 356–63.
8. Van Naarden Braun K, Doernberg N, Schieve L, Christensen D, Goodman A, Yeargin-Allsopp M. Birth prevalence of cerebral palsy: a population-based study. Pediatrics 2016; 137: 1–9.
9. Winter S, Autry A, Boyle C, Yeargin-Allsopp M. Trends in the prevalence of cerebral palsy in a population-based study. Pediatrics 2002; 110: 1220–25.
10. Numata Y, Onuma A, Kobayashi Y, et al. Brain magnetic resonance imaging and motor and intellectual functioning in 86 patients born at term with spastic diplegia. Dev Med Child Neurol 2013; 55: 167–72.
11. Costeff H. Estimated frequency of genetic and nongenetic causes of congenital idiopathic cerebral palsy in west Sweden. Ann Hum Genet 2004; 68: 515–20.
12. MacLennan AH, Thompson SC, Gecz J. Cerebral palsy: causes, pathways, and the role of genetic variants. Am J Obstet Gynecol 2015; 213: 779–88.
13. Moreno-De-Luca A, Ledbetter DH, Martin CL. Genetic [corrected] insights into the causes and classification of [corrected] cerebral palsies. Lancet Neurol 2012; 11: 283–92.
14. Lee RW, Poretti A, Cohen JS, et al. A diagnostic approach for cerebral palsy in the genomic era. NeuroMol Med 2014; 16: 821–44.
15. Rosenbaum P, Paneth N, Leviton A, et al. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol 2007; 109: 8–14.
16. Cho SC, Yim SH, Yoo HK, et al. Copy number variations associated with idiopathic autism identified by whole-genome microarray-based comparative genomic hybridization. Psychiatr Genet 2009; 19: 177–85.
17. Christian SL, Brune CW, Sudi J, et al. Novel submicroscopic chromosomal abnormalities detected in autism spectrum disorder. Biol Psychiatry 2008; 63: 1111–17.
18. de la Torre-Ubieta L, Won H, Stein JL, Geschwind DH. Advancing the understanding of autism disease mechanisms through genetics. Nat Med 2016; 22: 345–61.
19. Derrick M, Drobyshevsky A, Ji X, Tan S. A model of cerebral palsy from fetal hypoxia-ischemia. Stroke 2007; 38: 731–35.
20. McMichael G, Girirajan S, Moreno-De-Luca A, et al. Rare copy number variation in cerebral palsy. Eur J Hum Genet 2014; 22: 40–45.
21. Segel R, Ben-Pazi H, Zeligson S, et al. Copy number variations in cryptogenic cerebral palsy. Neurology 2015; 84: 1660–68.
22. Oskoui M, Gazzellone MJ, Thiruvahindrapuram B, et al. Clinically relevant copy number variations detected in cerebral palsy. Nat Commun 2015; 6: 7949.
23. Kruer MC, Jepperson T, Dutta S, et al. Mutations in gamma adducin are associated with inherited cerebral palsy. Ann Neurol 2013; 74: 805–14.
24. Verkerk AJ, Schot R, Dumee B, et al. Mutation in the AP4M1 gene provides a model for neuroaxonal injury in cerebral palsy. Am J Hum Genet 2009; 85: 40–52.
25. Wu D, Zou YF, Xu XY, et al. The association of genetic polymorphisms with cerebral palsy: a meta-analysis. Dev Med Child Neurol 2011; 53: 217–25.
26. Kuroda MM, Weck ME, Sarwark JF, Hamidullah A, Wainwright MS. Association of apolipoprotein E genotype and cerebral palsy in children. Pediatrics 2007; 119: 306–13.
27. Xu Y, Wang H, Sun Y, et al. The association of apolipoprotein E gene polymorphisms with cerebral palsy in Chinese infants. Mol Genet Genomics 2014; 289: 411–16.
28. Lien E, Andersen GL, Bao Y, et al. Apolipoprotein E polymorphisms and severity of cerebral palsy: a cross-sectional study in 255 children in Norway. Dev Med Child Neurol 2013; 55: 372–77.
29. Stoknes M, Lien E, Andersen GL, et al. Child apolipoprotein E gene variants and risk of cerebral palsy: estimation from case-parent triads. Eur J Paediatr Neurol 2015; 19: 286–91.
30. McMichael GL, Gibson CS, Goldwater PN, et al. Association between apolipoprotein E genotype and cerebral palsy is not confirmed in a Caucasian population. Hum Genet 2008; 124: 411–16.
31. Braga LW, Borigato EV, Speck-Martins CE, et al. Apolipoprotein E genotype and cerebral palsy. Dev Med Child Neurol 2010; 52: 666–71.
32. Blackman JA, Gordish-Dressman H, Bao Y, Matsumoto JA, Sinkin RA. The apolipoprotein gene and recovery from brain injury among extremely preterm infants. Neonatology 2014; 105: 227–29.
33. Schaefer GB. Genetics considerations in cerebral palsy. Semin Pediatr Neurol 2008; 15: 21–26.
34. Torres VM, Saddi VA. Systematic review: hereditary thrombophilia associated to pediatric strokes and cerebral palsy. J Pediatr (Rio J) 2015; 91: 22–29.
35. Nelson KB. Thrombophilias, perinatal stroke, and cerebral palsy. Clin Obstet Gynecol 2006; 49: 875–84.
36. Bei F, Lee HH, Liu X, et al. Restoration of visual function by enhancing conduction in regenerated axons. Cell 2016; 164: 219–32.
37. Shang Q, Zhou C, Liu D, et al. Association between osteopontin gene polymorphisms and cerebral palsy in a Chinese population. NeuroMol Med 2016; 18: 232–38.
38. Jacquemont S, Coe BP, Hersch M, et al. A higher mutational burden in females supports a “female protective model” in neurodevelopmental disorders. Am J Hum Genet 2014; 94: 415–25.
39. Lerer I, Sagi M, Meiner V, Cohen T, Zlotogora J, Abeliovich D. Deletion of the ANKRD15 gene at 9p24.3 causes parent-of-origin-dependent inheritance of familial cerebral palsy. Hum Mol Genet 2005; 14: 3911–20.
40. McMichael G, Bainbridge MN, Haan E, et al. Whole-exome sequencing points to considerable genetic heterogeneity of cerebral palsy. Mol Psychiatry 2015; 20: 176–82.
41. Parolin Schnekenberg R, Perkins EM, Miller JW, et al. De novo point mutations in patients diagnosed with ataxic cerebral palsy. Brain 2015; 138: 1817–32.
42. Figueroa KP, Waters MF, Garibyan V, et al. Frequency of KCNC3 DNA variants as causes of spinocerebellar ataxia 13 (SCA13). PLoS ONE 2011; 6: e17811.
43. Lise S, Clarkson Y, Perkins E, et al. Recessive mutations in SPTBN2 implicate beta-III spectrin in both cognitive and motor development. PLoS Genet 2012; 8: e1003074.
44. Huang L, Chardon JW, Carter MT, et al. Missense mutations in ITPR1 cause autosomal dominant congenital nonprogressive spinocerebellar ataxia. Orphanet J Rare Dis 2012; 7: 67.
45. Kakinuma N, Kiyama R. A major mutation of KIF21A associated with congenital fibrosis of the extraocular muscles type 1 (CFEOM1) enhances translocation of Kank1 to the membrane. Biochem Biophys Res Commun 2009; 386: 639–44.
46. Clohisey SM, Dzhindzhev NS, Ohkura H. Kank is an EB1 interacting protein that localises to muscle-tendon attachment sites in Drosophila. PLoS ONE 2014; 9: e106112.
47. Vanzo RJ, Martin MM, Sdano MR, South ST. Familial KANK1 deletion that does not follow expected imprinting pattern. Eur J Med Genet 2013; 56: 256–59.
48. Gee HY, Zhang F, Ashraf S, et al. KANK deficiency leads to podocyte dysfunction and nephrotic syndrome. J Clin Invest 2015; 125: 2375–84.
49. Moreno-De-Luca A, Helmers SL, Mao H, et al. Adaptor protein complex-4 (AP-4) deficiency causes a novel autosomal recessive cerebral palsy syndrome with microcephaly and intellectual disability. J Med Genet 2011; 48: 141–44.
50. Abou Jamra R, Philippe O, Raas-Rothschild A, et al. Adaptor protein complex 4 deficiency causes severe autosomal-recessive intellectual disability, progressive spastic paraplegia, shy character, and short stature. Am J Hum Genet 2011; 88: 788–95.
51. Follett PL, Deng W, Dai W, et al. Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate. J Neurosci 2004; 24: 4412–20.
52. Matsuda S, Miura E, Matsuda K, et al. Accumulation of AMPA receptors in autophagosomes in neuronal axons lacking adaptor protein AP-4. Neuron 2008; 57: 730–45.
53. Back SA, Riddle A, Dean J, Hohimer AR. The instrumented fetal sheep as a model of cerebral white matter injury in the premature infant. Neurotherapeutics 2012; 9: 359–70.
54. Drobyshevsky A, Jiang R, Lin L, et al. Unmyelinated axon loss with postnatal hypertonia after fetal hypoxia. Ann Neurol 2014; 75: 533–41.
55. Gunn AJ, Bennet L. Fetal hypoxia insults and patterns of brain injury: insights from animal models. Clin Perinatol 2009; 36: 579–93.
56. Chien S, Reiter LT, Bier E, Gribskov M. Homophila: human disease gene cognates in Drosophila. Nucleic Acids Res 2002; 30: 149–51.
57. Howe K, Clark MD, Torroja CF, et al. The zebrafish reference genome sequence and its relationship to the human genome. Nature 2013; 496: 498–503.
58. Lin CY, Chiang CY, Tsai HJ. Zebrafish and Medaka: new model organisms for modern biomedical research. J Biomed Sci 2016; 23: 19.
59. Ugur B, Chen K, Bellen HJ. Drosophila tools and assays for the study of human diseases. Dis Model Mech 2016; 9: 235–44.
60. Lamprecht R. The actin cytoskeleton in memory formation. Prog Neurobiol 2014; 117: 1–19.
61. Ojelade SA, Acevedo SF, Rothenfluh A. The role of the actin cytoskeleton in regulating Drosophila behavior. Rev Neurosci 2013; 24: 471–84.
62. Cook M, Bolkan BJ, Kretzschmar D. Increased actin polymerization and stabilization interferes with neuronal function and survival in the AMPKgamma mutant Loechrig. PLoS ONE 2014; 9: e89847.
63. Cook M, Mani P, Wentzell JS, Kretzschmar D. Increased RhoA prenylation in the loechrig (loe) mutant leads to progressive neurodegeneration. PLoS ONE 2012; 7: e44440.
64. Goate A, Chartier-Harlin MC, Mullan M, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991; 349: 704–06.
65. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997; 276: 2045–47.
66. MacLennan AH. The genetic basis to cerebral palsy: seek and ye shall find. O & G Magazine (The Royal Australian and New Zealand College of Obstetricians and Gynaecologists) 2016; 18: 48–51.